Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112225697B reveals a green chiral resolution method for chloroquine phosphate, offering high purity and scalable supply chain solutions for global pharmaceutical manufacturers.
Patent CN100392090C details a novel enzymatic resolution for L/D-Methionine-15N. Achieve high isotopic abundance and optical purity with scalable biocatalytic processes.
Patent CN109400521B reveals a green, high-yield route for Avibactam intermediates. Discover cost reduction in API manufacturing and scalable supply solutions.
Patent CN100336803C details a scalable resolution method for difluorophenylalanine, offering high purity and cost-effective supply chain solutions for pharma.
Patent CN1062604C details enzymatic DL-Methionine resolution. Achieves high yield and purity. Offers cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN102728407B details a waste-utilizing synthesis for chiral salen catalysts, offering cost reduction in pharmaceutical intermediate manufacturing via single-solvent processes.
Advanced manufacturing process for thrombotic disorder API intermediates. Reduces costs via novel crystallization and resolution techniques described in patent CN1351600A.
Patent CN114621985B reveals enzymatic synthesis breakthrough. Delivers high purity and supply chain reliability for global pharmaceutical intermediate procurement strategies.
Patent CN114621986B reveals enzymatic synthesis for optically pure Taxol side chains. Discover cost-effective, scalable manufacturing solutions for pharmaceutical intermediates.
Patent CN104529958B details a scalable Ramelteon synthesis. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel three-step synthesis for Ramelteon intermediates ensuring high purity and scalable supply chain solutions for global pharmaceutical manufacturers.
Patent CN114921507B reveals lipase resolution for 2-oxabicyclo-[3.3.0]oct-6-en-3-one. High purity, green process, reliable supply chain for pharmaceutical intermediates.
Novel enzymatic Mitsunobu route for high-purity chiral intermediates. Reduces cost and improves yield for pharmaceutical manufacturing supply chains globally.
Patent CN109534957B details a scalable chemical resolution route for S-(-)-2-methyl-3-phenyl-1-propanol, offering significant cost reduction and supply chain stability for chiral intermediates.
Novel biocatalytic resolution method for high-purity dextro-cis-chrysanthemic acid. Simplifies production, reduces costs, and ensures supply chain stability for pyrethroid manufacturers.
Patent CN110467580A enables high-purity Lesinurad resolution using quinoline alkaloids, ensuring cost reduction and supply reliability for pharmaceutical intermediates.
Patent CN1122030C details a novel D-IP3 synthesis reducing chromatography. Discover cost-effective manufacturing and high-purity inositol phosphate supply solutions.
Patent CN102442994A details a novel atmospheric racemization method for S-Lipoic Acid, enabling cost-effective production of high-purity R-Lipoic Acid intermediates.
Novel enzymatic resolution route for high-purity Alzheimer's intermediate. Reduces cost and improves scalability for pharma manufacturing.
Patent CN114891838B reveals enzymatic resolution for dorzolamide intermediate. Achieve high purity and cost efficiency with scalable manufacturing processes.